Request Demo
Last update 09 Jun 2025
Nuwacell Biotechnologies Co., Ltd.
Last update 09 Jun 2025
Overview
Tags
Neoplasms
Hemic and Lymphatic Diseases
Immune System Diseases
Natural Killer Cell Therapies
Induced pluripotent stem cells (iPSC)
Mesenchymal stem cell therapy
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
No Data
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
NCT06978920
A Phase I, Open Label, Single Arm, Dose Escalation and Dose Expansion Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Human Induced Pluripotent Stem Cell Derived Dopaminergic Progenitor Cells (NCR201) Injection in the Treatment of Subjects With Parkinson's Disease
CTR20241207
探索NCR300注射液治疗较高风险或复发/难治性骨髓增生异常综合征患者的安全性、耐受性、药代动力学特征和初步疗效的开放、多剂量、剂量递增的Ⅰ期临床研究
[Translation] An open-label, multi-dose, dose-escalation Phase I clinical study to explore the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of NCR300 injection in the treatment of patients with higher-risk or relapsed/refractory myelodysplastic syndrome
CTR20251651
一项评价NCR102注射液治疗急性移植物抗宿主病（aGVHD）的安全性、有效性的I/II期临床研究
[Translation] A Phase I/II clinical study to evaluate the safety and efficacy of NCR102 injection in the treatment of acute graft-versus-host disease (aGVHD)
100 Clinical Results associated with Nuwacell Biotechnologies Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Nuwacell Biotechnologies Co., Ltd.
Login to view more data
100 Translational Medicine associated with Nuwacell Biotechnologies Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 15 Jun 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
1
IND Application
Phase 1
1
4
Phase 2
Other
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free